Cite
HARVARD Citation
Jacquet, E. et al. (2018). Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients. European journal of cancer. pp. 93-101. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jacquet, E. et al. (2018). Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients. European journal of cancer. pp. 93-101. [Online].